Средства И Препараты

Japan's Astellas sees cancer drug fueling 29% p...

Pharmaceutical Technology

Astellas Pharma Inc. (4503N.MX) stock price, ne...

Astellas Offloads 5 Legacy Products to Germany’...

Home | Astellas Pharma Canada, Inc.

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

Astellas gets FDA priority review for gastric c...

US FDA approves Astellas Pharma pill for menopa...

Astellas Home page | Astellas Pharma Inc.

Astellas

Astellas Pharma

FDA Grants Full Approval for Astellas Pharma's ...

Astellas Home page | Astellas Pharma Inc.

Asia Business Daily on Twitter: "Astellas Pharm...

Astellas licenses 4DMT’s AAV vector for ophthal...

Astellas Sues Over New Myrbetriq Patent to Reca...

Astellas Pharma Projects :: Photos, videos, log...

Атлас лекарственных растений - YouTube

Главная | Astellas Pharma Russia

China Formally Arrests Japanese Employee of Dru...

FDA Approves Astellas’ Non-hormonal Menopause T...

Astellas Pharma US on LinkedIn: FDA Grants Prio...

Astellas Pharma EMEA celebrates its 10th annive...

FDA blocks Astellas’ Claudin cancer drug over m...

Astellas introduces sustainable community initi...

Astellas Pharma to acquire Propella Therapeutic...

Astellas Pharma Joins Record Bond Sales by Japa...

Главная | Astellas Pharma Russia

Astellas' Prostate Cancer Drug Available In Jap...

Astellas, University of Tokyo extend partnershi...

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

About | Astellas Pharma Ltd

Astellas Pharmaceuticals Establishes Open Innov...

Astellas Pharma: A Contrarian Investment (OTCMK...

Astellas Pharma - Global Web Site on Behance